The Value of Strategic Alliances vs. Transactional CRO-Sponsor Relationships

Tim Dietlin, Vice President of Alliance Development, INC Research

In his role as Vice President, Alliance Development, Mr. Dietlin is focused on identifying and developing strategic alliance relationships with INC Research customers. Alliances are defined as relationships in which INC Research owns a non-competitive status with a customer for a specific type or amount of work—whether functional outsourcing, co-development of a compound, management of a therapeutic area or entire pipeline, or sharing in the risk and reward of a compound’s success.

Mr. Dietlin comes to INC Research after almost eight years at Campbell Alliance, a management consulting firm specialized in the pharmaceutical industry. While at Campbell, he founded and held leadership positions in consulting practices focused in both Clinical Development and Medical Affairs. Mr. Dietlin’s clients at Campbell included Amgen, GSK, J&J, Genentech, Onyx, and Pfizer, as well as several CROs. In this capacity he worked directly with CMOs, VPs of Clinical Development, and heads of Clinical Operations and Clinical Data Management. Mr. Dietlin holds a BA from Loyola University Chicago and an MBA from DePaul University. He is based in Chicago.

David Gillogly, Global Head, Clinical Contracting and Category Management, Novartis

In September 2009, David Gillogly was appointed Global Head of Clinical Contracting and Category Management, at Novartis Pharmaceuticals Corporation in East Hanover, New Jersey. David brings over 20 years of pharmaceutical experience focused in outsourcing, clinical operations, finance, and consulting. He most recently served as Senior Director of Strategic Partnerships at Daiichi Sankyo, where he provided leadership in developing outsourcing strategies, processes, and partnerships. Earlier in his career, he became one of the industry’s first outsourcing managers with Marion Merrell Dow and was a founding member of the Pharmaceutical Outsourcing Management Association (POMA). He also participated in developing a large outsourcing alliance between Hoechst Marion Roussel and Quintiles.

Prior to joining Daiichi Sankyo, he served as Director of Clinical Operations at TAP and as an industry consultant with PricewaterhouseCoopers where he provided outsourcing strategy expertise.

A University of Kansas graduate, David earned both a B.S. Degree and M.B.A. with a focus on Business Administration. He has additional course studies in healthcare administration from Wichita State University.